Utility of MRI in prostate cancer
10.2185/jjrm.56.624
- Author:
Masami NIWA
;
Hideto ANDO
;
Itaru HIRAMATSU
;
Eriko ITO
;
Tuneo WATANABE
;
Masao FUJIMOTO
;
Daisuke MISAWA
;
Nobuhito ONOGI
;
Takuya KOIDE
;
Manabu OKANO
- Publication Type:Journal Article
- MeSH:
Cancer of Prostate;
biopsy characteristics;
Magnetic Resonance Imaging;
GLEASON GRADING FOR PROSTATIC CANCER;
lower case pea
- From:Journal of the Japanese Association of Rural Medicine
2007;56(4):624-631
- CountryJapan
- Language:Japanese
-
Abstract:
For diagnosis of prostate cancer, MRI was performed in 91 patients prior to prostate biopsy, and prostate cancer was detected in 37 patients. The ability of MRI diagnosis compared with biopsy was accuracy 0.84, sensitivity 0.95, and specificity 0.76.In 26 patients (14 patients with prostate cancer) from whom MR images were obtained by diffusion weighted imaging, ADC value and PSA value showed a reverse correlation significantly.The ADC value was 0.97±0.23-3mm2/sec in the cancer area, 1.51±0.20-3mm2/sec in the normal peripheral zone, and 1.47±0.12-3mm2/sec in the normal central zone. The ADC value in the cancer area was smaller than that in the normal peripheral area or in the normal central zone significantly (p<0.001).The relation between ADC value and Gleason score did not show any correlation. However, when the Gleason score was under 6, ADC value was 1.11±0.20-3mm2/sec, and when it was over 7, ADC value was 0.81±0.19-3mm2/sec which showed a lower value than the ADC value with Gleason score under 6 significantly (p<0.05).MRI was effective for visualization of prostate cancer. We concluded that pre-biopsy MRI in prostate cancer would allow not only systemic-biopsy but also accurate targeting-biopsy, and it would improve the diagnosric ability of biopsy.
